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OBJECTIVE: To describe growth and clinical evolution of very low birth weight infants fed during hospital stay with
milk from a human milk bank according to the caloric-protein value.
METHOD: Forty very low birth weight infants were included: 10 were fed milk from their own mothers (GI), and
30 (GII) were fed human milk bank . 700 cal/L and 2 g/dL of protein. Growth curves were adjusted using nonlinear
regression to the measured growth parameters.
RESULTS: full enteral diet was reached in 6.3 days by GI and in 10.8 by GII; a weight of 2 kg was reached in 7.3 weeks
for GI and in 7.8 for GII. In GI, 3/10 (33.3%) and in GII, 7/30 (23.3%) developed sepsis. Necrotizing enterocolitis
did not occur in GI, but in 3/30 (10.0%) in GII. GI presented with urinary calcium . 4 mg/L in 1/10 (10.0%),
urinary phosphorus (Pu) ,1 mg/L in 10/10 (100%), and Ca/Cr .0.6 ratio in 1/10 (10.0%) of the cases; in GII, no
children presented alterations of the urinary calcium or the Ca and Cr ratio, and Pu was ,1 mg/L in 19/30 (63.3%). In
terms of growth the 50th percentile for GI was a weight gain of 12.1 g/day (GI) vs. 15.8 g/day (GII), a length gain of
0.75 cm/week (GI) vs. 1.02 cm/week (GII), and a head circumference gain of 0.74 cm/week (GI) vs. 0.76 cm/week (GII).
CONCLUSIONS: Human milk bank allowed a satisfactory growth and good clinical evolution for very low birth
weight infants.
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INTRODUCTION
Maternal milk (HM) is considered the gold standard to
nourish very low birth weight infants (VLBWIs).
VLBWIs benefit from the immunological and nutritional
composition of HM, which, during the period of four to six
weeks post-birth, has a higher concentration of proteins,
lipids, calories, sodium and IgA and smaller concentration
of lactose than the mature milk making it adapted for
premature needs. The more premature, the higher the
protein and lipid contents of the HM.1
With the evolution of lactation, there is a reduction of the
immunologic factors, caloric-protein and mineral concentra-
tion in HM, especially calcium and phosphorus,2 a fact that
makes some researchers question its indication for VLBWIs,
especially for those with birth weights lower than 1500 g.3-5
With the aim of obtaining benefits from HM for VLBWIs
feeding, various studies were developed using HM supple-
mented with heterologous protein, energy and minerals,
especially calcium, phosphorous and sodium, confirming
higher weight, linear growth and head circumference (HC)
gains as well as a lesser incidence of osseous metabolic
disease.5-8 However, HM with additives and the use of
formulas designed for preterm infants are not exempt from
complications such as necrotizing enterocolitis (NEC) nor,
in the long run, from the accelerated growth especially in
the first weeks of life that can cause obesity in childhood
and future metabolic syndromes.9
The institution of human milk banks has created a new
perspective for VLBWI nutrition. With the lack of mother’s
milk, the donor’s milk can be a good alternative for VLBWIs,
and donor’s milk has advantages in comparison to the use
of formulas, especially in terms of a smaller risk of infection,
NEC, metabolic disorders and better feeding progres-
sion.10,11 However, there are few studies in the literature
on VLBWIs fed with donated milk.
Due to the variations in each donated milk sample and in
the nutritional needs of each VLBWI, we studied the use of
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milk from a human milk bank that was selected according to
the caloric and protein value (HMB) for VLBWI feeding.
Herein, we describe the postnatal growth of these children
until they reach two kilograms of weight during their
hospital stay and their clinical-laboratorial evolution during
internment.
MATERIALS AND METHODS
Studied cases included 40 VLBWIs (birth weight# 1500 g),
without intrauterine growth restriction according to the
Kramer criteria.12 VLBWIs using medications that alter
protein metabolism, corticosteroids and/or diuretic medica-
tion for more than two weeks, those not able to receive enteral
feeding for more than a week, and those with major
malformations in multiple organs or system dysfunctions
were excluded from the study.
The VLBWIs were classified into two study groups:
Group I (GI) included 10 VLBWIs who received milk from
their own mothers, either drawn and raw or pasteurized.
Group II (GII) included 30 VLBWIs with a birth weight
# 1500 g, without intrauterine growth restriction, who
received human milk from a bank previously classified
for containing more than 60% protein and calories of the
total ingested value. The division of the study groups
occurred naturally according to the mother’s milk produc-
tion and the need for complementation with HMB. The
study was approved by the ethical Board of Sa˜o Paulo
University Clinics Hospital and University Hospital of
Sa˜o Bernardo do Campo (HMU). The milk used in this
research study to GI was the milk from the infants’ own
mothers, raw or pasteurized, and to GII was mainly
transition or mature donated milk from the HMB with a
caloric value . 700 kcal/L and a protein value . 2.0 g/dl.
For those VLBWIs that received minimal enteral feeding,
the selected milk as preferably the raw colostrums or
pasteurized milk from their mothers. In the lack of mother’s
milk, pasteurized colostra from the milk up to 600 kcal/L and
with protein contents varying from 2 to 3 g/dL, were offered.
In terms of collection, storage, pasteurization and quality
control, the milk used in this protocol complies with
Brazilian legislation, i.e., the administrative rules of the
Ministry of Health regulating the implementation and
operation of HMB.13
The HMB caloric value was determined through the
crematocrit technique,14 and the protein value was carried
out through the Biuret technique.15
In the study period, 15,283 samples of HM were analyzed,
out of which 1370 (8.9%) were selected for protein
concentration dosing for having more than 700 kcal/L; out
of these, 623 (45.4%) had more than 2 g/dL of proteins.
The milk samples were selected with the aim of offering the
VLBWIs 120 kcal/kg/day and 2.5 to 3.5 g/kg/day protein.
This proposal is based on the Polberger study,6 which
considers that an offer above this caloric-protein density has
no growth advantage and only causes higher fat deposition.
The referred values are close to those proposed by Tsang et
al.16 and by the Nutrition Committee of the European Society
of Pediatrics, Gastroenterology and Nutrition.17 The initial
offered volume ranged from 10 to 20 mL/kg/day and was
increased according to the tolerance of each child.
During the hospital stay, feeding progression and clinical
events such as incidence of sepsis, NEC and bronchopul-
monary dysplasia were analyzed. Additionally, calcium and
phosphorus (serum and urine), urea, creatinine, hemoglobin
(HB) and hematocrit (Hct) were dosed.18-21
Statistical analysis
The type of study was prospective, observational and
sequential with VLBWIs cut type outlining during the
hospital stay.
Parametric and nonparametric tests were utilized when
the obtained sample was relatively small or presented data
variability. The Shapiro-Wilk test was utilized to verify
the normality and the Mann-Witney test to compare the
nonparametric variables medians.
Elaboration of growth curves
From data regarding weight, HC and length, nonlinear
regression equations that were best adjusted to the individual
growth parameters for each infant were established.
Utilizing the CurvExpertH 1.3 software, various models
were selected to mimic the growth tendency that each child
presented and to obtain a high correlation coefficient allied
to a smaller formula standard error. In this manner, the
following equations were selected:
N Third-degree polynomial: Y = a+bx+cx2+ dx3
N Fourth-degree polynomial: y = a+bx+cx2+ dx3+ ex4
N Fifth-degree polynomial: y = a+bx+cx2+dx3+ex4+fx5
N Heat Capacity Model: Y = a+bx+c/x2
N Sinusoidal: Y = a+bcos(cx+d)
N Count = a+bx+clogx
N Hyperbolic: y = a+b/x
N Exponential: y = ae b/x
From the equation defined for each VLBWI, through
interpolation, the values of weight, length and HC were
estimated at weekly intervals, from 28 until 39 exact weeks
of corrected GA. Utilizing these data, for each exact age
(weeks), each parameter’s mean value was calculated. Based
on the mean values, regression curves that were better
adjusted to the VLBWI group growth as a whole were
established by utilizing the same software and the same
described criteria. This is able to smooth out the erratic
character that is usually observed in curves based on actual
values.
The best adjustment curve for the three parameters in the
different ages was a third-degree polynomial.
Results
In the study period, 11,342 children were born in the
hospital HMU, and 1051 of them with GA less than
37 weeks, out of which 195 weighed , 1500 g; of these, 57
(29.2%) were characterized as not having intrauterine
growth restriction. Seventeen VLBWI were excluded from
the study according to the established exclusion criteria.
Table 1 shows the GI and GII distribution according to
birth weight. The groups were similar in terms of birth
weight range (1251 g to 1500 g); however, 42.5% of infants in
GII weighed less than 1250 g, while this was true for only
20.0% of infants in GI.
The enteral nutrition progress regarding feeding progres-
sion, beginning of enteral feeding and full volume to meet
the preconized nutritional needs was satisfactory and very
quick. At the end of the first week, few children were on
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parenteral nutrition, and most of them had a good caloric-
protein ingestion (Table 1).
As shown in Table 1, there were few complications and no
differences related to oral feeding such as NEC and other
complications associated with prematurity. Otherwise, the
incidence of sepsis was low in both groups.
Laboratory assessment (Table 1) of hemoglobin and
hematocrit showed no correlation between the use of
human milk and the evolution of anemia in the studied
cases. Serum urea and creatinine were higher and signifi-
cant (p = 0,0246) in GII which could indicates a greater
amount of ingested protein.
The study also monitored possible laboratory phos-
phorous deficiency21 and when necessary, corrected it
through the use of a calcium and phosphorous manipulated
formula. As shown in Table 2, there was no evidence of
Osseous Metabolic Disease, but we did observe phosphorus
deficiency.
The values obtained in the VLBWI growth parameters of
both groups in regard to weight, length and HC expressed
in percentiles, for each GA, are shown in Tables 3 (GI) and 4
(GII). The graphs corresponding to these tables for the 5th,
50th and 95th percentiles are shown for weight, length and
HC in Figures 1, 2 and 3, respectively.
Tables 3 and 4 show values obtained in length and HC of
both groups (GI and GII) are virtually the same for all
percentiles. In regards to weight, the same tables show that
the median weight achieved in the corresponding age of
39 weeks of gestation is almost the same; however, the GII
had a wider range of values between the median and the
extreme percentiles than were observed in GI.
Nevertheless, when considering growth during the study
period, Figures 1, 2 and 3 show that both groups presented
equal trends and that the gain in weight ( p = 0,0002) and
length ( p = 0,0038) was higher and significant in GII than GI.
DISCUSSION
Currently, the consensus is that HM is the better nutrient
for VLBWIs. However, there are doubts about its adequacy
after the 3rd week from birth, especially for those with birth
weights below 1250 g.8,22
The nutritional strategies currently utilized are formulated
to increase human milk caloric-protein, mineral and vitamins
value, or complement the human milk with formulas
appropriate for premature infants. With the lack of HM, or
when its complementation is necessary, HMB can be a good
option;23 however, according to some authors,24,25 this
product might not be nutritionally appropriate. This was
shown by studies utilizing HMB during the mature milk stage
that came from full-term newborn mothers, which displayed
protein and mineral contents insufficient to allow a growth
similar to the intrauterine growth in VLBWI.26
However, it is worth mentioning that these studies
developed with donor HM did not detail the quality control
of samples, such as the cold chain and titratable acidity,
which are important in the reduction in loss of immunolo-
gical components and in the maintenance of nutrients.
Moreover, these studies did not analyze the protein and
caloric contents of the offered HM. It should also be
considered that donated HM is obtained through milk-
drawing that is done according to the donor need: some use
relief milk-drawing, i.e., after milking, due to large milk
production, breasts are emptied to avoid ingurgitation. This
procedure favors the collection of more caloric milk that is
mainly composed of the emulsion fraction; on the other
Table 1 - Group I and Group II studied cases in regards to weight, enteral progression and clinical - laboratory data.
GI GII p
Infants (n) 10 30
Gestational age (weeks) 30.3 ¡ 1.1 29.6 ¡ 2.6 0,4165 (NS)
Newborn weight (g) 1305 ¡ 197 1198 ¡ 231 0,1975 (NS)
Full enteral diet (days) 6.3 ¡ 4.3 10.8 ¡ 6.4 0,1383 (NS)
Recovery to newborn weight (days) 7.8 ¡ 5.8 10.6 ¡ 4.0 0,0960 (NS)
Weeks to reach 2 Kg 7.3 ¡ 2.0 7.8 ¡ 1.9 0,4810 (NS)
Necrotizing enterocolitis - 3 (10.0%) (2IA/1IB)* 0,5597 (NS)
Sepsis incidence 3 (33.3%) (2E/1La) 7 (23.3%) (3E/4La)** 0,6893 (NS)
Bronchopulmonary dysplasia 3 (33.3%) (L) 9 (30.0%) (8L/1M)*** 1,000 (NS)
Hemoglobin (g/dL) 14.1 ¡ 3.6 12.7 ¡ 4.9 0,4123 (NS)
Hematocrit (%) 40.6 ¡ 11.1 36.2 ¡ 11.4 0,2942 (NS)
Urea (mg/dL) 12.0 ¡ 5.3 19.5 ¡ 9.6 0,0246 (S)
Creatinine (mg/dL) 0.2 ¡ 0.11 0.3 ¡ 0.16 0,751 (NS)
Normal laboratory values:30
Hemoglobin: 9.0–14.0 g/dL
Hematocrit: 28–42%
Urea: 5–18mg/dL
Creatinine: 0.2–0.4mg/dl
*Necrotizing enterocolitis (NEC) - Bell criterion modified by Walsh and Kliegmann, 198619
**Sepsis – Bone et al. criteria, 199118
***Bronchopulmonary dysplasia - Ehrenkranz, 200520
E – early; La – late; L – light; and M – moderate
NS = no significant, S = significant
Table 2 - Serum and urinary values of Ca, P, FA, and Ca/Cr
ratio in GI (n = 10) and in GII (n = 30).
Group I Group II
pVariable n % n %
Blood Ps,3.6 mg/dL 3 30.0 16 53.3 0,2812(NS)
FA . 900 UL 7 70.0 17 56.6 0,7110(NS)
Urine *CaU.4 mg/L 1 10.0 - - 0,2500(NS)
*PU,1 mg/L 10 100.0 19 63.3 0,0381(S)
*Ca/Cr.0.6 1 10.0 - - 0,2500(NS)
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hand, when the donor draws milk between milking or uses
dripping milk, the caloric value is lower because this is the
solution fraction.27 Therefore, the nutritional and immuno-
logical composition of the donated HM can be modified due
to various factors including period of lactation.
HMB samples were selected as described to meet the
medical prescription according to the needs of the VLBWIs
and their evolution period. The initial offered volume
ranged from 10 to 20 mL/kg/day and was increased
according to the child’s tolerance. When possible, the
mother’s own HM was utilized. In this manner, the group
division naturally occurred according to the need for
supplementation with HMB.
Enteral feeding had an early start, and the time to reach full
enteral feeding in the stable growth phase in GI was 6.3 ¡
4.3 days and was 10.8¡ 6.4 days in GII (Table 01). A relevant
comparison was the difference found by Schanler et al.28 who
observed an elapsed time of 28¡ 7 days to reach full enteral
feeding utilizing supplemented HM and 36 ¡ 17 days in
children fed with formula for premature infants.
When comparing the birth weight recovery time in GI and
GII, we observed, on average, 7.8 ¡ 5.8 days in GI and
Table 3 - Evolution of Weight (w), Length (l) and Head Circumference (HC) percentiles (P3 to 97), according to the
corrected gestational age, estimated through interpolation from the equation defined for each VLBWI of GI (n = 10).
Weeks 28 29 30 31 32 33 34 35 36 37 38 39
Weight (g) P3 736.63 895.29 1043.20 1060.99 1167.87 1334.80 1544.25 1701.24 1719.47 1995.29
P5 800.32 943.00 1085.24 1113.88 1223.89 1388.30 1577.23 1726.03 1756.98 2002.45
P10 898.28 1016.37 1149.90 1195.25 1310.06 1470.60 1627.96 1764.15 1814.68 2013.47
P50 1280.00 1295.00 1372.75 1458.73 1520.00 1691.99 1838.81 1914.30 2005.00 2047.11
P90 1590.23 1534.66 1606.59 1769.94 1918.68 2051.91 1986.27 2033.45 2222.22 2091.27
P95 1688.19 1608.03 1671.25 1851.31 2004.85 2134.21 2037.00 2071.57 2279.92 2102.29
P97 1751.88 1655.74 1713.28 1904.20 2060.87 2187.71 2069.98 2096.36 2317.43 2109.45
Weeks 28 29 30 31 32 33 34 35 36 37 38 39
Length P3 34.30 35.97 36.94 37.82 38.77 39.93 41.03 41.11 42.63 42.04
(cm) P5 34.70 36.29 37.28 38.15 39.09 40.21 41.24 41.38 42.85 42.41
P10 35.31 36.79 37.79 38.66 39.59 40.64 41.56 41.80 43.19 42.98
P50 38.00 38.60 39.70 40.30 41.10 42.00 42.65 43.50 44.40 44.50
P90 39.65 40.30 41.43 42.26 43.07 43.66 43.82 44.75 45.58 46.96
P95 40.26 40.80 41.94 42.77 43.57 44.09 44.14 45.17 45.92 47.52
P97 40.66 41.12 42.28 43.10 43.89 44.37 44.35 45.44 46.14 47.89
Weeks 28 29 30 31 32 33 34 35 36 37 38 39
HC (cm) P3 24.46 25.43 26.61 27.36 27.90 28.28 29.69 30.78 31.68 32.16
P5 24.79 25.70 26.83 27.60 28.19 28.64 29.90 30.93 31.83 32.28
P10 25.30 26.11 27.18 27.96 28.65 29.20 30.22 31.17 32.06 32.46
P50 26.40 27.50 28.30 29.25 30.00 30.75 31.05 31.80 32.60 33.10
P90 28.90 29.02 29.59 30.56 31.89 33.12 32.50 32.83 33.68 33.74
P95 29.41 29.43 29.93 30.92 32.35 33.68 32.83 33.07 33.91 33.92
P97 29.74 29.70 30.15 31.16 32.64 34.04 33.04 33.22 34.05 34.04
Table 4 - Evolution of Weight (w), Length (l) and Head Circumference (HC) percentiles (P3 to P97), according to the
corrected gestational age, estimated through interpolation from the equation defined for each VLBWI of GII (n = 30).
Weeks 28 29 30 31 32 33 34 35 36 37 38 39
Weight (g) p3 837.28 745.19 815.65 894.21 1008.68 1079.76 1185.11 1312.30 1441.05 1625.25 1799.29 1756.75
p5 843.23 771.65 859.17 931.70 1045.57 1118.34 1224.50 1350.36 1478.73 1656.02 1821.34 1791.76
p10 852.40 812.35 926.13 989.38 1102.31 1177.68 1285.09 1408.92 1536.69 1703.35 1855.26 1845.62
p50 887.50 940.50 1145.00 1193.70 1330.50 1395.00 1505.00 1609.30 1728.80 1849.40 1987.20 2106.70
p90 917.10 1099.85 1399.03 1396.74 1503.10 1596.85 1713.09 1822.52 1946.06 2037.69 2094.83 2226.02
p95 926.27 1140.55 1465.98 1454.41 1559.84 1656.20 1773.68 1881.07 2004.02 2085.02 2128.75 2279.88
p97 932.22 1167.01 1509.51 1491.91 1596.74 1694.78 1813.07 1919.14 2041.70 2115.79 2150.80 2314.89
Weeks 28 29 30 31 32 33 34 35 36 37 38 39
Length (cm) p3 31.58 33.25 34.28 34.72 35.84 36.65 37.64 38.33 39.17 39.80 41.25 43.03
p5 31.94 33.55 34.65 35.10 36.18 37.00 37.98 38.68 39.56 40.23 41.56 43.26
p10 32.48 34.01 35.22 35.68 36.72 37.53 38.49 39.22 40.16 40.89 42.04 43.61
p50 33.80 35.25 37.00 37.40 38.50 39.50 40.20 41.00 42.25 43.20 44.10 45.10
p90 36.36 37.26 39.26 39.80 40.47 41.31 42.14 43.07 44.38 45.57 45.42 46.07
p95 36.90 37.72 39.83 40.38 41.01 41.84 42.65 43.61 44.97 46.23 45.89 46.42
p97 37.26 38.01 40.21 40.76 41.35 42.19 42.99 43.97 45.36 46.66 46.20 46.65
Weeks 28 29 30 31 32 33 34 35 36 37 38 39
HC (cm) p3 23.50 22.34 23.83 24.87 25.46 26.13 26.94 27.83 28.71 29.58 30.63 32.00
p5 23.58 22.67 24.16 25.15 25.75 26.41 27.22 28.10 28.97 29.82 30.81 32.09
p10 23.70 23.17 24.67 25.58 26.19 26.84 27.64 28.51 29.36 30.17 31.08 32.24
p50 24.15 24.60 27.00 27.10 27.65 28.30 28.95 29.80 30.80 31.20 31.90 32.60
p90 24.55 26.76 28.31 28.62 29.32 29.89 30.65 31.44 32.16 32.68 32.99 33.29
p95 24.67 27.27 28.83 29.05 29.76 30.33 31.08 31.86 32.56 33.04 33.26 33.44
p97 24.75 27.60 29.16 29.33 30.04 30.61 31.35 32.13 32.81 33.27 33.44 33.54
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10.6¡ 4.0 days in GII (Table 01). Gross et al.26 compared the
weight gain of the three VLBWI groups with GA between 27–
33 weeks and birth weight, 1500 g. One group was fed with
the first week’s milk (colostra and transition milk) obtained
from VLBWI mothers, another group was fed with mature
milk from full-term newborn mothers, and a third group was
fed with lacteal formula. Those fed with lacteal formula
recovered their birth weight in 10.3¡ 0.8 days, those fed with
VLBWI mother’s milk recovered in 11.4¡ 0.8 days, and those
using mature milk recovered in 18.8¡ 1.7 days. In this study,
the authors utilized a pool of human milk from various
donors stored until a year after pasteurization, a procedure
that is not utilized in Brazil.13 It should be noted that the
components of HMB obtained through the pool are medianly
distributed, and therefore the children receiving it do not
benefit from the changes in composition of drawn milk.
In regard to the time elapsed to reach 2 kg, there was no
difference between groups. On average, GI took 7.3 ¡
2 weeks and GII took 7.8 ¡ 1.9 weeks (Table 1).
These results are similar to the results from a study by
Schanler et al.28, which compared VLBWIs fed with supple-
mented HM and preterm formula. They found an average
time to reach 2 kg of 8.4 ¡ 1.8 weeks with the use of
supplemented HM and 7.2 ¡ 1.7 weeks with formula for
VLBWIs. The results suggest that the early introduction of
pasteurized HM or HMB allows for a good enteral feeding
progression and a very appropriate average time to reach 2 kg.
As for clinical events, in GII, 3/30 (10.0%) children had
suspect light NEC with good clinical evolution, and there
were no cases of NEC in GI. In regard to sepsis, there were
3/10 (33.3%) cases in GI and 7/30 (23.3%) cases in GII
(Table 1). Schanler et al.29 found a 6% incidence of NEC in
the group of children fed with donor HM, 11% in the group
of preterm formula, and 6% in the HM group; sepsis
incidence was 29% in the group of children fed with donor
milk, 23% in the maternal milk group, and 30% in the group
using formula.
The incidence of sepsis in the group using HMB was the
same found in the group using HM, similar to what was
previously described by Schanler et al.28
Bronchopulmonary dysplasia (BD), occurred in 3/10
(30.0%) cases in GI and GII 9/30 (30.0%) cases in: 1/30
(3.3%) presented moderate and 8/30 (26.6%) presented light
BD (Table 01).
In the studied cases, there was no significant difference of
clinical complications when comparing HMB and the
mother’s own milk probably due to the preservation of
donated HMB protection factors, resulting from quality
control techniques used in the National HMB Network.13
This study monitored the phosphorous deficiency21 and
corrected it when necessary through the use of a calcium
and phosphorous manipulated formula (Table 2). GI
presented urinary calcium . 4 mg/L in 1/10 (10.0%),
urinary phosphorus ,1 mg/L in 10/10 (100%), and Ca/Cr
ratio . 0.6 in 1/10 (10.0%) of the cases; in GII, none of the
children presented alterations in urinary calcium values,
although 19/30 (63.3%) presented urinary phosphorus
,1 mg/L. This made us conclude that the urinary excretion
of phosphorus was more prolonged and intense in GI than
in GII (p = 0,0381), which evolved more adequately, show-
ing economy in phosphorous excretion.
These results suggest that HMB with higher caloric value
mostly composed of the suspension and emulsion fraction
than the solution fraction has more casein in the colloidal
solution with calcium and phosphorus, which causes a
higher concentration of these ions. In spite of this, the
phosphorous serum level was found to be low in 3/10
(30.0%) of the GI children and in 16/30 (53.3%) of group II,
and the alkaline phosphatase was . 900 UL in 7/10 (70.0%)
of GI children and 17/30 (56.6%) of GII children (Table 2).
These results show the need for continuous Osseous
Metabolic Disease monitoring through the control of serum
and urinary calcium and phosphorus when indicated by
laboratorial parameters.
The growth analysis shows that for GI, the anthropo-
metric data for the construction of curves were computed
from the value that each child presented in the 30th week of
CGA; when analyzed between the 30th and 39th week of
CGA, we verified an average weight gain of 12.1 g/day,
length of 0.75 cm/week and HC of 0.74 cm/week in the 50th
percentile (p50) of the curve (Table 3; Figures 1, 2 and 3).
As for GII, from the 28th to the 39th week of CGA, in
regard to p50, the average weight gain was 15.8 g per day;
Figure 1 - Estimated values of 5th, 50th and 95th percentiles of GI
and GII VLBWIs (in g).
Figure 3 - Estimated values of 5th, 50th and 95th percentiles of GI
and GII VLBWI Head Circumference (HC in cm).
Figure 2 - Estimated values of 5th, 50th and 95th percentiles of GI
and GII VLBWI length (in cm).
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however, if we stratify this period, we verified that the
weight gain was 14.5 g/day between the 28th and the 31st
week of CGA, 11.6 g/day between the 32nd and the 34th
week, and 17.7 g/day between the 35th and 39th week
(Table 4 and Figure 1). The phase of lesser weight gain
between the 32nd and 34th week coincides with the moment
when non-nutritive breast milk suction started, which might
have caused an energetic expenditure above that when the
nursing bottle or little cup was used.
In regards to the length of GII, the increase was 1.02 cm/
week, and the HC growth was 0.76 cm/week (Table 4 and
Figure 2,3).
In 2005, Schanler et al.29 observed a weight gain of 17.1¡
5.0 g/kg/day, length of 1.2¡ 0.8 cm/week and HC of 0.9¡
0.9 cm/week in the group fed milk from donor mothers. In
the group fed preterm formula, the weight gain was 20.1¡
6.7 g/kg/day, length was 1.0 ¡ 1.0 cm/week and HC was
0.9¡ 0.8 cm/week. The maternal milk group gained 18.8¡
5.8 g/kg/day in weight, length of 0.6 ¡ 0.4 cm/week
and CP of 0.8 ¡ 0.5 cm/week. In another study,28 by
utilizing HM with additives, the obtained weight gain was
22 ¡ 7 g/kg/day, length was 0.79 ¡ 0.27 cm/day and HC
was 0.88¡ 0.26 cm/day. Compared with the studied cases,
the weight gain was superior in all groups; however,
children in the present study took 7 weeks on average to
reach 2 kg in weight and had very similar gains in length
and HC, which means that the smaller weight losses soon
after birth and the faster recovery of birth weight compen-
sated for the smaller weight gain later on.
An important aspect observed in this study are the
growth curves with proportionality in the three studied
parameters (weight, length and HC), showing the adequacy
of the offered diet (Figures 1, 2 and 3).
Studies with donated HMB in general utilize HM pools,
which are extremely vulnerable products with few con-
trolled studies of its physical-chemical quality and caloric
and protein value, which are indispensable aspects. Without
this information, there are great possibilities of offering
a product that does not meet the VLBWI nutritional
needs.7,13,29
By determining the properties of each milk sample,
despite the period of lactation (colostra, transition or mature
milk), we have the possibility to individualize the VLBWI
needs and offer a more appropriate HMB in regard to its
caloric-protein composition for each phase of the child’s
growth. Quality control of donated human milk established
by the Brazilian laws governing human milk bank13 allows
for a better quality product with minimal immunologic and
nutritional loss. The usual determination of crematocrit plus
that of protein makes the HMB choice economically feasible,
for the crematocrit cost is insignificant and the protein
dosage is about US$0.50/sample.
We conclude that HMB utilization is an important
strategy in the nutrition of VLBWIs to promote a satisfactory
growth with good clinical evolution and should be
considered in neonatology services structured with a
human milk bank.
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